SIRT6 and prostate cancer: Numerous tumor tissues, such as those from colon cancer, breast cancer, ovarian cancer, hepatocellular carcinoma, osteosarcoma, prostate cancer, and renal cell carcinoma, exhibit increased expression of Sirt6, a Sirt family member [2–7].